Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
Go back to Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada| (NYSE: HIMS) | Delayed: 33.57 -1.9 (5.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.47 | 52 Week High | $ | |||
| Open | $34.63 | 52 Week Low | $ | |||
| Day High | $35.99 | P/E | N/A | |||
| Day Low | $33.41 | EPS | $ | |||
| Volume | 14,588,065 | |||||

